House bill seeks 5-year biologics exclusivity period

Rep. Jan Schakowsky (D-Ill.) has introduced legislation that could bring biosimilars to the U.S. market faster by shortening the exclusivity period for biologics from 12 to 5 years.

Co-sponsors of H.R. 3379 include one Republican, Bruce Westerman (R-Ark.), and 14 Democrats. ...